PMEF
EBS icon

Point72 Middle East FZE’s Emergent Biosolutions EBS Stock Holding History

Point72 Middle East FZE’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-81,032
Closed -$194K – 412
2023
Q4 		$194K Sell
81,032
-131,144
-62% -$308K 0.01% 1055
2023
Q3 		$721K Buy
+212,176
New +$1.18M 0.02% 683
2023
Q2 		– Sell
-36,336
Closed -$376K – 1676
2023
Q1 		$376K Buy
+36,336
New +$439K 0.01% 761

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Middle East FZE's EBS Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 81,032 shares — an estimated $194K sold.

Point72 Middle East FZE first reported a position in EBS in Q1 2023 and held it in 3 quarters. The position peaked at $721K in Q3 2023. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 81,032 Emergent Biosolutions shares in Q1 2024, an estimated $194K.
  • Point72 Middle East FZE first reported a position in Emergent Biosolutions in Q1 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Emergent Biosolutions position peaked at $721K in Q3 2023.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.